跳至主要内容
临床试验/ISRCTN37381706
ISRCTN37381706已完成不适用

Efficacy of three nutraceutical products of herbal origin in weight management of obese human subjects: a randomised, double blind, placebo controlled clinical study

aila Nutraceuticals (India)0 个研究点目标入组 100 人开始时间: 2007年11月22日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Adults aged 21 - 50 years
  • 2. Body Mass Index (BMI) greater than or equal to 30 kg/m^2
  • 3. Willingness to participate in an exercise-walking program, supervised by a trained exercise specialist
  • 4. Willingness to consume the prescribed study diet of approximately 2,000 KCal per day as outlined in the protocol (meals will be provided at free of cost by the study sponsor)
  • 5. Written informed consent to participate in the trial
  • 6. Willingness to complete standard health history questionnaire before induction into the study
  • 7. Willingness to participate in five clinic visits (screening, baseline, 2, 4 & 8 weeks)
  • 8. If female:
  • 8.1. Should be negative in pregnancy test
  • 8.2. If of childbearing potential, should agree to follow an acceptable method of birth control for the duration of the study, such as condoms, foams, jellies, diaphragm, Intrauterine Device (IUD), etc.
  • 8.3. Postmenopausal for at least 1 year
  • 8.4. Surgically sterile (bilateral tubal ligation, bilateral oophorectomy, or hysterectomy)

排除标准

  • 1. History of thyroid disease or cardiovascular disease or diabetes
  • 2. Any other clinically significant disorder
  • 3. History of allergy to spices and herbal products
  • 4. Intractable obesity or uncontrolled body weight, BMI greater than 40 kg/m^2
  • 5. Presently using other weight loss medications, as well as stimulants, laxatives or diuretics taken solely for the purpose of weight loss
  • 6. Recent, unexplained weight loss or gain
  • 7. Positive Human Immunodeficiency Virus (HIV) test
  • 8. History of hepatitis, pancreatitis, lactic acidosis or hepatomegaly with steatosis
  • 9. History of motor weakness or peripheral sensory neuropathy
  • 10. Any evidence of organ dysfunction or any clinically significant deviation from the normal, in physical or clinical determinations

研究者

发起方
aila Nutraceuticals (India)

相似试验